Just like Liu et al. [220], Chen et al. [222] proved that FOXM1 was upregulated in resistant cells, while its downregulation improved 5-FU sensitivity in drug-resistant CRC cells. The gene discussed is FOXM1; the disease is colorectal carcinoma.